| Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients J Niu, G Andres, K Kramer, MN Kundranda, RH Alvarez, E Klimant, ... OncoTargets and therapy, 3323-3328, 2015 | 67 | 2015 |
| Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy G Li, D Pavlick, JH Chung, T Bauer, BA Tan, J Peguero, P Ward, A Kallab, ... Journal of Gastrointestinal Oncology 10 (5), 831, 2019 | 40 | 2019 |
| Metastasis of lung adenosquamous carcinoma to meningioma: case report with literature review R Glass, SR Hukku, B Gershenhorn, J Alzate, B Tan International Journal of Clinical and Experimental Pathology 6 (11), 2625, 2013 | 32 | 2013 |
| Colon carcinoma with unusual metastasis to the esophagus manifesting as multiple nodules and dysphagia: management with systemic chemotherapy PG Vashi, D Gupta, B Tan Case Reports in Gastroenterology 6 (2), 484-488, 2012 | 6 | 2012 |
| Initial experience with genomic profiling of heavily pretreated breast cancers ED Staren, D Braun, B Tan, D Gupta, S Kim, K Kramer, M Markman Annals of surgical oncology 21, 3216-3222, 2014 | 5 | 2014 |
| Mutational landscape of endometrial cancer identified by prospective clinical sequencing in a nationwide cancer network. JC Schink, RH Alvarez, JA Elvin, A Moran, R Rollins, JP Geisler, ... Journal of Clinical Oncology 37 (15_suppl), e17123-e17123, 2019 | 3 | 2019 |
| Comparison of comprehensive genomic profiling (CGP) and hotspot next generation sequencing (NGS) assays in identifying treatment options for care of patients with metastatic … RH Alvarez, JW Thomas, ZR Chalmers, AB Schrock, CA Tapias, ... Journal of Clinical Oncology 34 (15_suppl), e23120-e23120, 2016 | 3 | 2016 |
| Increased collection efficiency of Spectra OPTIA reduces the blood volume processed to acquire targeted CD34+ dose C Gottsacker, A Akinwande, T Loos, M Payne, SA Abutalib, B Tan Biology of Blood and Marrow Transplantation 21 (2), S147-S148, 2015 | 2 | 2015 |
| Racial differences in the mutational landscape of serous endometrial cancer. JC Schink, R Garg, B Buttin, JA Elvin, N Godbee, A Moran, V Doctor, ... Journal of Clinical Oncology 40 (16_suppl), 5600-5600, 2022 | 1 | 2022 |
| Key drivers of physician decision-making in utilizing next generation sequencing results to guide cancer therapy. D Gupta, S Zook, H Kuhah, A Nazari, K Kramer, PA Crilley, BA Tan, ... Journal of Clinical Oncology 34 (15_suppl), e18101-e18101, 2016 | 1 | 2016 |
| Next-generation sequencing (NGS) to identify potential therapeutic targets in advanced pancreatic cancer. MN Kundranda, DP Braun, K Kramer, J Ai, BA Tan, E Kilmant, GL River, ... Journal of Clinical Oncology 33 (3_suppl), 357-357, 2015 | 1 | 2015 |
| Impact of clinical and genomic factors on outcomes for pancreatic adeoncarcinoma based on race KE Poruk, A Moran, V Doctor, JA Elvin, A Amini, B Tan, H Halabi, J Schink, ... HPB 25, S95, 2023 | | 2023 |
| Mutational landscape of low-grade serous carcinoma of the ovary. JC Schink, R Garg, JA Elvin, N Godbee, A Moran, V Doctor, BA Tan, ... Journal of Clinical Oncology 40 (16_suppl), 5578-5578, 2022 | | 2022 |
| Therapeutic implications of mutations in high grade serous ovarian carcinoma when evaluated by race. R Garg, JC Schink, B Buttin, JA Elvin, N Godbee, A Moran, V Doctor, ... Journal of clinical oncology 40 (16_suppl), e17590-e17590, 2022 | | 2022 |
| Mutational landscape of gynecologic cancers identified by prospective clinical sequencing in a nationwide cancer network JC Schink, RH Alvarez, JA Elvin, A Moran, KJ Manahan, JP Geisler, ... Gynecologic Oncology 154, 243-244, 2019 | | 2019 |
| Treatment of Patients With Lobular Breast Cancer Harboring Human Epidermal Growth Factor Receptor 2 Mutation With HER2-Directed Therapy DL Citrin, BA Tan, NB Patel, V Doctor, SM Ali, AR Parikh, M Markman, ... JCO Precision Oncology 2, 1-7, 2018 | | 2018 |
| Genomic testing for HER2 mutation in patients with metastatic lobular carcinoma of the breast. DL Citrin, A Kadamkulam Syriac, V Doctor, BA Tan Journal of Clinical Oncology 36 (15_suppl), e13022-e13022, 2018 | | 2018 |
| 1884 The incidence and clinical significance of ESR1 mutations in patients with heavily pretreated metastatic breast cancer J Niu, G Andres, K Kramer, M Kundranda, G Weiss, E Klimant, A Parikh, ... European Journal of Cancer 3 (51), S294, 2015 | | 2015 |
| Initial Experience With Genomic Profiling of Breast Cancers ED Staren, M Markman, D Braun, B Tan, KD Kramer, R Geana ANNALS OF SURGICAL ONCOLOGY 21, 7-7, 2014 | | 2014 |
